Somatrem is a recombinant human growth hormone used for the treatment of short stature due to decreased or absent secretion of endogenous growth hormone.
Somatrem was first marketed under the brand name Protropin by Genentech in 1985.[2] It differs from endogenous growth hormone by the addition of an extra methionine at the N-terminus[3][circular reference].
Somatrem has largely been replaced by somatropin, marketed by several companies including by Genentech as the brand Nutropin.
Referencesedit
^Flodh H (1987). "Present situation worldwide regarding the use and clinical experience of Somatonorm (somatrem)". Acta Paediatrica Scandinavica. Supplement. 331: 1–4. doi:10.1111/j.1651-2227.1987.tb17089.x. PMID 3300150. S2CID 20410776.
^"Genentech: Press Releases - Friday, Oct 18, 1985". www.gene.com.
somatrem, this, article, needs, additional, citations, verification, please, help, improve, this, article, adding, citations, reliable, sources, unsourced, material, challenged, removed, find, sources, news, newspapers, books, scholar, jstor, june, 2019, learn. This article needs additional citations for verification Please help improve this article by adding citations to reliable sources Unsourced material may be challenged and removed Find sources Somatrem news newspapers books scholar JSTOR June 2019 Learn how and when to remove this message Somatrem sold under the brand name Protropin is an analogue of growth hormone GH 1 SomatremClinical dataTrade namesProtropinAHFS Drugs comMicromedex Detailed Consumer InformationATC codeH01AC02 WHO IdentifiersCAS Number82030 87 3 NDrugBankDB09098 YChemSpidernoneUNIICU8D464EDWKEGGD05884 YChEMBLChEMBL1201620 NChemical and physical dataFormulaC 995H 1537N 263O 301S 8Molar mass22256 26 g mol 1 N Y what is this verify Overview editSomatrem is a recombinant human growth hormone used for the treatment of short stature due to decreased or absent secretion of endogenous growth hormone Somatrem was first marketed under the brand name Protropin by Genentech in 1985 2 It differs from endogenous growth hormone by the addition of an extra methionine at the N terminus 3 circular reference Somatrem has largely been replaced by somatropin marketed by several companies including by Genentech as the brand Nutropin References edit Flodh H 1987 Present situation worldwide regarding the use and clinical experience of Somatonorm somatrem Acta Paediatrica Scandinavica Supplement 331 1 4 doi 10 1111 j 1651 2227 1987 tb17089 x PMID 3300150 S2CID 20410776 Genentech Press Releases Friday Oct 18 1985 www gene com Growth hormone therapy cite note 32External links edit Somatrem Drug Information Portal HyperGH 14x Growth Hormone Info Portal nbsp Medicine nbsp This hormonal preparation article is a stub You can help Wikipedia by expanding it vte Retrieved from https en wikipedia org w index php title Somatrem amp oldid 1190946204, wikipedia, wiki, book, books, library,
